Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Jan-24 4:08 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jan-24 | Grant | 3,341 | -- | -- | < 1% 779.37K to 782.71K | |
| 20-Nov-23 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Nov-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 779.37K to 780.62K | |
| 20-Nov-23 4:18 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Nov-23 | Planned Option Sale | 1,250 | $47.74 | $59,675.00 | (< 1%) 780.62K to 779.37K | |
| 18-Oct-23 5:43 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Oct-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 779.37K to 780.62K | |
| 18-Oct-23 5:43 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Oct-23 | Planned Option Sale | 1,250 | $48.50 | $60,625.00 | (< 1%) 780.62K to 779.37K | |
| 19-Sep-23 5:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Sep-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 779.37K to 780.62K | |
| 19-Sep-23 5:05 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 18-Sep-23 | Planned Option Sale | 1,250 | $45.00 | $56,250.00 | (< 1%) 780.62K to 779.37K | |
| 18-Sep-23 4:24 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Sep-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 779.37K to 780.62K | |
| 18-Sep-23 4:24 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Sep-23 | Planned Option Sale | 1,250 | $45.34 | $56,675.00 | (< 1%) 780.62K to 779.37K | |
| 24-Jul-23 5:01 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jul-23 | Option Exercise | 49,779 | $2.67 | $132,910.00 | 7% 729.59K to 779.37K | |
| 21-Jul-23 4:13 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jul-23 | Option Exercise | 50,000 | $2.67 | $133,500.00 | 7% 679.59K to 729.59K | |
| 18-Jul-23 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Jul-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 679.59K to 680.84K | |
| 18-Jul-23 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Jul-23 | Planned Option Sale | 1,250 | $64.79 | $80,987.50 | (< 1%) 680.84K to 679.59K | |
| 21-Jun-23 4:34 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jun-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 679.59K to 680.84K | |
| 21-Jun-23 4:34 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jun-23 | Planned Option Sale | 1,250 | $88.41 | $110,513.00 | (< 1%) 680.84K to 679.59K | |
| 18-May-23 5:12 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-May-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 679.59K to 680.84K | |
| 18-May-23 5:12 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-May-23 | Planned Option Sale | 1,250 | $88.66 | $110,825.00 | (< 1%) 680.84K to 679.59K | |
| 18-Apr-23 4:30 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Apr-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 679.59K to 680.84K | |
| 18-Apr-23 4:30 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Apr-23 | Planned Option Sale | 1,250 | $81.05 | $101,312.00 | (< 1%) 680.84K to 679.59K | |
| 21-Mar-23 4:35 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Mar-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 679.59K to 680.84K | |
| 21-Mar-23 4:35 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Mar-23 | Planned Option Sale | 1,250 | $64.03 | $80,037.50 | (< 1%) 680.84K to 679.59K | |
| 21-Feb-23 4:22 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Feb-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 679.59K to 680.84K | |
| 21-Feb-23 4:22 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Feb-23 | Planned Option Sale | 1,250 | $52.38 | $65,475.00 | (< 1%) 680.84K to 679.59K | |
| 19-Jan-23 4:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Jan-23 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 679.59K to 680.84K | |
| 19-Jan-23 4:55 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Jan-23 | Planned Option Sale | 1,250 | $52.42 | $65,525.00 | (< 1%) 680.84K to 679.59K | |
| 04-Jan-23 5:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jan-23 | Grant | 3,867 | -- | -- | < 1% 675.72K to 679.59K | |
| 19-Dec-22 4:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Dec-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 19-Dec-22 4:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Dec-22 | Planned Option Sale | 1,250 | $52.35 | $65,437.50 | (< 1%) 676.97K to 675.72K | |
| 17-Nov-22 4:33 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Nov-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 17-Nov-22 4:33 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Nov-22 | Planned Option Sale | 1,250 | $48.01 | $60,012.50 | (< 1%) 676.97K to 675.72K | |
| 17-Oct-22 5:57 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Oct-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 17-Oct-22 5:57 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Oct-22 | Planned Option Sale | 1,250 | $59.31 | $74,137.50 | (< 1%) 676.97K to 675.72K | |
| 16-Sep-22 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Sep-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 16-Sep-22 4:03 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Sep-22 | Planned Option Sale | 1,250 | $66.00 | $82,500.00 | (< 1%) 676.97K to 675.72K | |
| 16-Aug-22 5:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Aug-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 16-Aug-22 5:00 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Aug-22 | Planned Option Sale | 1,250 | $67.21 | $84,012.50 | (< 1%) 676.97K to 675.72K | |
| 18-Jul-22 5:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Jul-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 18-Jul-22 5:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Jul-22 | Planned Option Sale | 1,250 | $46.33 | $57,912.50 | (< 1%) 676.97K to 675.72K | |
| 17-Jun-22 5:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Jun-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 17-Jun-22 5:02 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Jun-22 | Planned Option Sale | 1,250 | $39.29 | $49,112.50 | (< 1%) 676.97K to 675.72K | |
| 17-May-22 5:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-May-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 17-May-22 5:26 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-May-22 | Planned Option Sale | 1,250 | $39.18 | $48,975.00 | (< 1%) 676.97K to 675.72K | |
| 18-Apr-22 7:42 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Apr-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 18-Apr-22 7:42 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Apr-22 | Planned Option Sale | 1,250 | $50.90 | $63,625.00 | (< 1%) 676.97K to 675.72K | |
| 17-Mar-22 8:59 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Mar-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 671.49K to 672.74K | |
| 17-Mar-22 8:59 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Mar-22 | Planned Option Sale | 1,250 | $39.57 | $49,462.50 | (< 1%) 672.74K to 671.49K | |
| 16-Feb-22 4:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Feb-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 16-Feb-22 4:29 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 15-Feb-22 | Planned Option Sale | 1,250 | $45.43 | $56,787.50 | (< 1%) 676.97K to 675.72K | |
| 19-Jan-22 8:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Jan-22 | Option Exercise | 1,250 | $2.67 | $3,337.50 | < 1% 675.72K to 676.97K | |
| 19-Jan-22 8:15 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 14-Jan-22 | Planned Option Sale | 1,250 | $40.56 | $50,700.00 | (< 1%) 676.97K to 675.72K |